Submission for OMB Review; Comment Request Generic Clearance to Conduct Voluntary Customer/Partner Surveys, 34391-34392 [2012-14140]
Download as PDF
<![CDATA[
34391
Federal Register / Vol. 77, No. 112 / Monday, June 11, 2012 / Notices
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: Nursing Scholarship
Program (OMB No. 0915–0301)—
[Revision]
The Nursing Scholarship Program
(NSP) is a competitive Federal program,
which awards scholarships to
individuals for attendance at accredited
schools of nursing. The Bureau of
Clinician Recruitment and Service
(BCRS) in HRSA administers the
program. The scholarship consists of
payment of tuition, fees, other
reasonable educational costs, and a
monthly support stipend. In return, the
students agree to provide a minimum of
2 years of full-time clinical service (or
an equivalent part-time commitment, as
approved by the NSP) at a health care
facility with a critical shortage of nurses
as defined by the program.
NSP recipients must be willing to and
are required to fulfill their NSP service
commitment at a health care facility
with a critical shortage of nurses in the
United States, which includes, in
addition to the States, the District of
Columbia, Guam, the Commonwealth of
Puerto Rico, the Northern Mariana
Islands, the U.S. Virgin Islands,
American Samoa, the Federated States
of Micronesia, the Republic of the
Marshall Islands, and the Republic of
Palau. Students who are uncertain of
their commitment to provide nursing
care in a health care facility with a
critical shortage of nurses in the United
States or these territories are advised not
to participate in this program.
The NSP needs to collect data to
determine an applicant’s eligibility for
the program, to monitor a participant’s
continued enrollment in a school of
nursing, to monitor the participant’s
compliance with the NSP service
Number of
respondents
Instrument
Responses
per
respondent
obligation, and to obtain data on its
program to ensure compliance with
statutory mandates and prepare annual
reports to Congress. The following
information will be collected: (1) From
the applicants and/or the schools—
general applicant and nursing school
data such as full name, location, tuition/
fees, and enrollment status; (2) from the
schools (on an annual basis)—data
concerning tuition/fees and student
enrollment status; and (3) from the
participants and their health care
facilities with a critical shortage of
nurses (on a biannual basis)—data
concerning the participant’s
employment status, work schedule, and
leave usage. BCRS enters the cost
information into its information data
system, along with the projected amount
for the monthly stipend, to determine
the amount of each scholarship award.
The annual estimate of burden is as
follows:
Total
responses
Hours per
response
Total burden
hours
Application ............................................................................
In-School Monitoring ............................................................
In-Service Monitoring ...........................................................
4,000
500
600
1
1
2
4,000
500
1,200
2
2
1
8,000
1,000
1,200
Total ..............................................................................
5,100
........................
5,700
........................
10,200
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by
email to
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Dated: June 5, 2012.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2012–14001 Filed 6–8–12; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
srobinson on DSK4SPTVN1PROD with NOTICES
National Institutes of Health
Submission for OMB Review;
Comment Request Generic Clearance
to Conduct Voluntary Customer/
Partner Surveys
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Library of Medicine (NLM), the National
Institutes of Health (NIH) has submitted
SUMMARY:
VerDate Mar<15>2010
20:21 Jun 08, 2012
Jkt 226001
to the Office of Management and Budget
(OMB) a request to review and approve
the information collection listed below.
This proposed information collection
was previously published in the Federal
Register on April 2, 2012 (Vol. 77, No.
63, p. 19673) and allowed 60-days for
public comment. A single public
comment was received. The purpose of
this notice is to allow an additional 30
days for public comment. The National
Institutes of Health may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
Proposed Collection: Title: Generic
Clearance to Conduct Voluntary
Customer/Partner Surveys; Type of
Information Collection Request:
Extension of currently approved
collection [OMB No. 0925–0476,
expiration date 06/30/2012] Form
Number: NA; Need and Use of
Information Collection: Executive Order
12962 directed agencies that provide
significant services directly to the
public to survey customers to determine
the kind and quality of services they
want and their level of satisfaction with
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
existing services. Additionally, since
1994, the NLM has been a ‘‘Federal
Reinvention Laboratory’’ with a goal of
improving its methods of delivering
information to the public. An essential
strategy in accomplishing reinvention
goals is the ability to periodically
receive input and feedback from
customers about the design and quality
of the services they receive. The NLM
provides significant services directly to
the public including health providers,
researchers, universities, other federal
agencies, state and local governments,
and to others through a range of
mechanisms, including publications,
technical assistance, and Web sites.
These services are primarily focused on
health and medical information
dissemination activities. The purpose of
this submission is to obtain OMB’s
generic approval to continue to conduct
satisfaction surveys of NLM’s
customers. The NLM will use the
information provided by individuals
and institutions to identify strengths
and weaknesses in current services and
to make improvements where feasible.
The ability to periodically survey NLM’s
customers is essential to continually
update and upgrade methods of
providing high quality service.
E:\FR\FM\11JNN1.SGM
11JNN1
34392
Federal Register / Vol. 77, No. 112 / Monday, June 11, 2012 / Notices
Frequency of Response: Annually or
biennially. Affected Public: Individuals
or households; businesses or other for
profit; state or local governments;
Federal agencies; non-profit institutions;
small businesses or organizations. Type
of Respondents: Organizations, medical
researchers, physicians and other health
Estimated
number of respondents
Types of respondents
Estimated
number of responses per
respondent
Average burden hours per
response
Estimated total
annual burden
hours requested
15,000
1
.150
2,250
srobinson on DSK4SPTVN1PROD with NOTICES
Researchers, Physicians, Other Health Care Providers, Librarians, Students, General Public ...................................................................................
The annualized cost to respondents for
each year of the generic clearance is
estimated to be $20,670. There are no
Capital Costs, Operating Costs, and/or
Maintenance Costs to report.
Request For Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact: David
Sharlip, National Library of Medicine,
Building 38A, Room B2N12, 8600
Rockville Pike, Bethesda, MD 20894, or
call non-toll free number 301–402–9680
or email your request to
sharlipd@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
VerDate Mar<15>2010
20:21 Jun 08, 2012
Jkt 226001
care providers, librarians, students, and
the general public. The annual reporting
burden is as follows:
Dated: June 5, 2012.
David H. Sharlip,
NLM Project Clearance Liaison, National
Library of Medicine, National Institutes of
Health.
[FR Doc. 2012–14140 Filed 6–8–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION: Licensing
information and copies of the U.S.
patent applications listed below may be
obtained by writing to the indicated
licensing contact at the Office of
Technology Transfer, National Institutes
of Health, 6011 Executive Boulevard,
Suite 325, Rockville, Maryland 20852–
3804; telephone: 301–496–7057; fax:
301–402–0220. A signed Confidential
Disclosure Agreement will be required
to receive copies of the patent
applications.
SUMMARY:
Treatment of Viral Infection by
Blocking Interleukin-21
Description of Technology: Blocking
interleukin (IL-21) may be an effective
method to treat or prevent various viral
infections. In the course of an immune
response to a virus, IL-21, produced
primarily by CD4∂ T cells, can inhibit
or stimulate (regulate), immune cell
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
function (B cells, T cells, natural killer
cells, dendritic cells). IL-21 regulation
may be either protective or pathological;
autoimmune disease pathology has been
associated with IL-21 promoted
inflammation (in: Type 1 diabetes,
lupus, and multiple sclerosis). This
technology describes methods of
blocking IL-21 that may reduce
damaging inflammatory responses
during certain viral infections.
Specifically, the absence of IL-21 during
respiratory viral infection such as
pneumonia virus infection actually
prevents some of the pathogenic effects
that may be promoted by IL-21. Methods
for controlling IL-21 signaling may be
used to treat to prevent many
pathological effects of pneumonia
viruses, and other viral infections.
Potential Commercial Applications:
Prevention and treatment of many
pathological effects of viral infections,
including pneumonia.
Competitive Advantages: New method
for treating viral infection pathology.
Development Stage:
• Early-stage.
• Pre-clinical.
• In vivo data available (animal).
Inventors: Warren J. Leonard and
Rosanne Spolski (NHLBI).
Publication: Spolski R, et al. IL-21
promotes the pathologic immune
response to pneumovirus infection. J
Immunol. 2012 Feb 15;188(4):1924–32.
[PMID 22238461].
Intellectual Property: HHS Reference
No. E–017–2012/0—U.S. Provisional
Application No. 61/579,801 filed 23 Dec
2011.
Licensing Contact: Tedd Fenn; 301–
435–5031; Tedd.Fenn.nih.gov.
Collaborative Research Opportunity:
The NHLBI is seeking statements of
capability or interest from parties
interested in collaborative research to
further develop, evaluate or
commercialize treatment of viral
infection by blocking Interleukin-21 (E–
017–2012). For collaboration
opportunities, please contact Vincent
Kolesnitchenko, Ph.D. at
kolesniv@nhlbi.nih.gov.
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 77, Number 112 (Monday, June 11, 2012)]
[Notices]
[Pages 34391-34392]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-14140]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request Generic Clearance to
Conduct Voluntary Customer/Partner Surveys
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Library of Medicine (NLM), the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request to review and approve the
information collection listed below. This proposed information
collection was previously published in the Federal Register on April 2,
2012 (Vol. 77, No. 63, p. 19673) and allowed 60-days for public
comment. A single public comment was received. The purpose of this
notice is to allow an additional 30 days for public comment. The
National Institutes of Health may not conduct or sponsor, and the
respondent is not required to respond to, an information collection
that has been extended, revised, or implemented on or after October 1,
1995, unless it displays a currently valid OMB control number.
Proposed Collection: Title: Generic Clearance to Conduct Voluntary
Customer/Partner Surveys; Type of Information Collection Request:
Extension of currently approved collection [OMB No. 0925-0476,
expiration date 06/30/2012] Form Number: NA; Need and Use of
Information Collection: Executive Order 12962 directed agencies that
provide significant services directly to the public to survey customers
to determine the kind and quality of services they want and their level
of satisfaction with existing services. Additionally, since 1994, the
NLM has been a ``Federal Reinvention Laboratory'' with a goal of
improving its methods of delivering information to the public. An
essential strategy in accomplishing reinvention goals is the ability to
periodically receive input and feedback from customers about the design
and quality of the services they receive. The NLM provides significant
services directly to the public including health providers,
researchers, universities, other federal agencies, state and local
governments, and to others through a range of mechanisms, including
publications, technical assistance, and Web sites. These services are
primarily focused on health and medical information dissemination
activities. The purpose of this submission is to obtain OMB's generic
approval to continue to conduct satisfaction surveys of NLM's
customers. The NLM will use the information provided by individuals and
institutions to identify strengths and weaknesses in current services
and to make improvements where feasible. The ability to periodically
survey NLM's customers is essential to continually update and upgrade
methods of providing high quality service.
[[Page 34392]]
Frequency of Response: Annually or biennially. Affected Public:
Individuals or households; businesses or other for profit; state or
local governments; Federal agencies; non-profit institutions; small
businesses or organizations. Type of Respondents: Organizations,
medical researchers, physicians and other health care providers,
librarians, students, and the general public. The annual reporting
burden is as follows:
----------------------------------------------------------------------------------------------------------------
Estimated Estimated
Estimated number of Average burden total annual
Types of respondents number of responses per hours per burden hours
respondents respondent response requested
----------------------------------------------------------------------------------------------------------------
Researchers, Physicians, Other Health Care 15,000 1 .150 2,250
Providers, Librarians, Students, General Public
----------------------------------------------------------------------------------------------------------------
The annualized cost to respondents for each year of the generic
clearance is estimated to be $20,670. There are no Capital Costs,
Operating Costs, and/or Maintenance Costs to report.
Request For Comments: Written comments and/or suggestions from the
public and affected agencies should address one or more of the
following points: (1) Evaluate whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Enhance the
quality, utility, and clarity of the information to be collected; and
(4) Minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: Desk Officer for NIH. To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: David Sharlip, National Library of Medicine,
Building 38A, Room B2N12, 8600 Rockville Pike, Bethesda, MD 20894, or
call non-toll free number 301-402-9680 or email your request to
sharlipd@mail.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
Dated: June 5, 2012.
David H. Sharlip,
NLM Project Clearance Liaison, National Library of Medicine, National
Institutes of Health.
[FR Doc. 2012-14140 Filed 6-8-12; 8:45 am]
BILLING CODE 4140-01-P
